Status:
RECRUITING
Prognostic Value of BNP in MCS - a 25 Year Follow up Study
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Heart Failure
Left Ventricular Assist Device
Eligibility:
All Genders
18+ years
Brief Summary
A biobank has been created to investigate the prognostic value of biomarkers (mainly BNP) in patients implanted with durable mechanical assist devices comparing patients with advanced HF supported by ...
Detailed Description
All patients referred for advanced HF treatment at the Dept of Cardiology at Rigshospitalet.
Eligibility Criteria
Inclusion
- All patients referred for evaluation for advanced HF treatment at the Rigshospital in Denmark
- Age\>18 years
Exclusion
- No consent
Key Trial Info
Start Date :
September 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2045
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04377854
Start Date
September 18 2020
End Date
August 1 2045
Last Update
May 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, DK, Denmark, 2100